HMOX1 and pulmonary arterial hypertension: Lastly, in a rat model of pediatric PAH, erythropoietin treatment reduces vessel wall thickness and the occlusion rate of intra-acinar vessels; however, this effect is abrogated following the blockade of HO-1 activity [130].